|
⚲
|
| Thomas Schuetz | |
|---|---|
| Firm | |
| Address | c/o Compass Therapeutics, Inc 245 First Street Cambridge, Ma 02142 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM ($M) |
|---|---|---|---|---|---|
| Compass Therapeutics Inc | 021-370115 | Executive Officer | 60.5 M of 70.0 M |
||
| Compass Therapeutics Inc | 021-370112 | Executive Officer | 195.3 M of 195.3 M |
||
| Compass Therapeutics LLC | 021-302629 | Executive Officer | 21.8 M of 50.0 M |
||
| Audentes Therapeutics Inc | 021-249874 | Director | 65.0 M of 65.0 M |
||
| Audentes Therapeutics Inc | 021-246838 | Director | |||
| Compass Therapeutics LLC | 021-242888 | Executive Officer | 110.2 M of 170.2 M |
||
| Audentes Therapeutics Inc | 021-230835 | Director | 42.5 M of 42.5 M |
||
| Relypsa Inc | 021-182532 | Director | 65.0 M of 80.0 M |
||
| Enobia Pharma Corp | 021-164842 | Director | 20.0 M of 40.0 M |
||
| Arteaus Therapeutics LLC | 021-163669 | Director | 15.6 M of 18.0 M |
||
| Enobia Pharma Corp | 021-157715 | Director | 15.0 M of 47.0 M |
||
| Relypsa Inc | 021-147705 | Director | 70.1 M of 70.1 M |
||
| Enobia Pharma Corp | 021-109028 | Director | 50.0 M of 50.0 M |
||